[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100132279":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":53,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (questionnaire)",null,"Patients undergoing standard of care proton therapy are assessed for toxicities weekly during proton treatment, then from 1 to 3 times up to 90 days from the start of treatment and annually thereafter. Patients also complete questionnaires over 15-20 minutes at baseline, weekly during treatment, and every 2 weeks during follow up for up to 3 months.",[13,14],"Other: Quality-of-Life Assessment","Other: Questionnaire Administration",[16,22],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"Quality-of-Life Assessment","Complete questionnaires",[9],[21],"Quality of Life Assessment",{"type":6,"name":23,"description":18,"armGroupLabels":24,"otherNames":10},"Questionnaire Administration",[9],[26],{"name":27,"affiliation":5,"role":28},"Steven J Frank","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Steven J. Frank","CONTACT","713-563-2300","sjfrank@mdanderson.org",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"M D Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-95.36327,29.76328,{"lat":48,"lon":47},[51,52],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":10},{"name":31,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100132279",false,"NCT00991094","Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy","Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults","Inclusion Criteria:\n\n* All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol\n* Patients must sign a study-specific consent form prior to study entry\n\nExclusion Criteria:\n\n* Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site","ALL","18 Years",{"count":64,"type":65},5000,"ESTIMATED","OBSERVATIONAL","This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.",[69,70,71,72,73,74,75,76,77],"Breast Carcinoma","Esophageal Carcinoma","Genitourinary System Carcinoma","Head and Neck Carcinoma","Hematopoietic and Lymphoid Cell Neoplasm","Lung Carcinoma","Malignant Central Nervous System Neoplasm","Malignant Digestive System Neoplasm","Malignant Solid Neoplasm","2026-06-10",{"date":80,"type":81},"2026-06-12","ACTUAL",{"date":83,"type":81},"2005-05-27",{"date":85,"type":65},"2027-12-31",{"name":5,"class":6},1]